Cambridge Healthtech Institute’s 10th Annual

Engineering Bispecific Antibodies
( 双特异性抗体工程 )

Improving Therapeutic Properties for Oncology and Beyond



The world of bispecific strategies, formats and clinical results has been gearing up over the past several years. Now in its tenth year, the Engineering Bispecific Antibodies conference was the first one in the community to address the vast challenges and exciting new engineering and manufacturing advances that are enabling the next generation of improved bispecific antibodies. Come see for yourself why this field is leading a transformation beyond oncology to many other areas of medicine.

Coverage will include key strategies and technologies to:

  • Design bispecific antibodies for CNS, oncology, hemophilia, infectious disease, ophthalmology, and inflammation 
  • Explore novel constructs and modes of delivery
  • Penetrate the blood brain barrier
  • Minimize off-target effects, immunogenicity and toxicity
  • Consider downstream developability
  • Engage new approaches for immunomodulation and immunotherapy
  • Establish best method for T cell activation and mechanism of action for checkpoint inhibition

* 活动内容有可能不事先告知作更动及调整。

Choose your language